Publikationen in Zusammenarbeit mit Forschern von Hospital Universitari Germans Trias i Pujol (8)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  2. Salivary biomarkers as pioneering indicators for diagnosis and severity stratification of pediatric long COVID

    Frontiers in Cellular and Infection Microbiology, Vol. 14

2020

  1. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status (Scientific Reports, (2020), 10, 1, (13553), 10.1038/s41598-020-70454-8)

    Scientific Reports

  2. Differences in the Interleukin-1β/Soluble ST2 Interplay Between Acute and Chronic Heart Failure

    Journal of Cardiovascular Translational Research

2019

  1. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure

    Journal of the American College of Cardiology, Vol. 73, Núm. 9, pp. 1016-1025

  2. Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes

    JACC: Basic to Translational Science, Vol. 4, Núm. 7, pp. 831-840

  3. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction

    Journal of Molecular and Cellular Cardiology, Vol. 130, pp. 216-233

2011

  1. Soluble ST2 is a marker for acute cardiac allograft rejection

    Annals of Thoracic Surgery, Vol. 92, Núm. 6, pp. 2118-2124